🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Excellent news from FDA ODAC - thanks to AQUILA team and to all the physicians & patients who testified today! Shared decision-making between pts & MDs will remain key to high-risk smoldering myeloma, and hopefully 🇺🇸 decision-making will involve daratumumab at some point 🤞🏼

The future of myeloma care will regularly include the word cure! open.substack.com/pub/rafaelfons…

Really proud to co-author this ASCO Educational Book on making clinical trials standard of care. Yelak Biru & I brought the patient perspective! His synopsis below is excellent- check it out!

Thrilled that Dr. Saad Usmani Saad Z. Usmani MD MBA FACP 🇺🇸🇵🇰 Chair of the myeloma program Memorial Sloan Kettering Cancer Center will receive the Giants of Cancer Care Award for Myeloma OncLive.com tomorrow. #ASCO25 Congrats dear friend! Best wishes on behalf of all our myeloma colleagues. Cheers!

New Definition of Light Chain Monoclonal Gammopathy of Undetermined Significance iStopMM JAMA Oncology #mmsm jamanetwork.com/journals/jamao… Important data coming to support need for new ranges of normal free light chains based on eGFR👇

The ASCO Ed Book is the highest-quality, peer-reviewed, free #oncology #MedEd ever. Whether or not you are attending #ASCO25, don’t miss out on this, #OncTwitter #MedTwitter, #MedStudentTwitter. Bookmark this tweet to keep the link handy: ascopubs.org/toc/edbk/curre… #OncoAlert

We need to streamline the process. My ECOG study is consistent with this timeline. I also just finished a call this Friday again, to harmonize the protocol. One of the most urgent needs is to expedite approved concepts through the system I really thank leaders Vincent Rajkumar

Amazing response rates with trispecific antibody JNJ-5322 in RR MM. N. van de Donk suggest it is as effective as BCMA targeting CART. In fections are still quite high. All patients should get prophylactic IgG replacement. 12 months PFS of 95%. Prophylactic toci significantly

In light of the CARTITUDE-1 trial outcome, I am grateful to BlackDoctor for writing this article about my myeloma journey! I would not call it beating... but I have survived almost 30 years with a cancer that is yet to be cured! "How I Beat a Deadly Cancer Nobody